Literature DB >> 5793755

A study of the metabolic fate of chlorpropamide in man.

P M Brotherton, P Grieveson, C McMartin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5793755     DOI： 10.1002/cpt1969104505

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

1.  The relationship between debrisoquine oxidation phenotype and the pharmacokinetics of chlorpropamide.

Authors:  J Kallio; R Huupponen; K Pyykkö
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The bioavailability in man of marketed brands of chlorpropamide.

Authors:  A M Monro; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  Pharmacokinetics of chlorpropamide in epileptic patients: effects of enzyme induction and urine pH on chlorpropamide elimination.

Authors:  P J Neuvonen; S Kärkkäinen; R Lehtovaara
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  [The mode of action of chlorpropamide in diabetes insipidus].

Authors:  E Uhlich; J Eigler; G Tryzna; K Finke; W Winkelmann; E Buchborn
Journal:  Klin Wochenschr       Date:  1971-03-15

Review 5.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 6.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

7.  Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.

Authors:  G Sartor; A Melander; B Scherstén; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

8.  Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

Authors:  Ji-Hong Shon; Young-Ran Yoon; Min-Jung Kim; Kyoung-Ah Kim; Young-Chae Lim; Kwang-Hyeon Liu; Dong-Hoon Shin; Chung Han Lee; In-June Cha; Jae-Gook Shin
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 9.  Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.

Authors:  A D Harrower
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

Review 10.  Drug interactions with oral sulphonylurea hypoglycaemic drugs.

Authors:  J M Hansen; L K Christensen
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.